12 02, 2025

Qkine and WildBio collaborate to progress cultivated meat from wild game species

2025-02-12T19:45:09+00:00February 12th, 2025|cellular agriculture, Collaboration, News, Press Release, stem cells|

For the cultivated meat industry, the goal is to produce a quality raw material quickly and at a reduced cost. At WildBio, with help from Qkine, we are harnessing the power of cells from wild game species in South Africa.

14 01, 2025

Protein tags, why and why not?

2025-01-14T13:00:28+00:00January 14th, 2025|animal-free, Blog, protein science, quality, Resources|

Protein tags are useful tools for affinity purification and other biochemical applications, but unnecessary tagging of proteins can cause issues. Read our latest blog and discover - Protein tags, why and why not?

18 12, 2024

Qkine join forces with Culturon to deliver cutting-edge solutions for the stem cell and life science industries

2024-12-18T09:58:40+00:00December 18th, 2024|News, Press Release|

We are delighted to share that Culturon and Qkine have joined forces to deliver cutting-edge solutions for the stem cell and life science industries.

18 11, 2024

Qkine and inscreenex collaborate to test cell models for drug discovery, disease modeling, and personalized medicine

2024-11-19T19:09:50+00:00November 18th, 2024|News, Press Release|

Through its pioneering cell-type-specific immortalization technology, inscreenex empowers scientists to overcome the limitations of primary cell cultures, offering long-lasting and functional cell lines that are ideal for applications in drug discovery, disease modeling, and personalized medicine. Collaboration with Qkine merges their expertise with that of Qkine in complex protein manufacturing and engineering to allow testing and validation of cell responses in disease modelling.

24 07, 2024

ISSCR 2024 reflections on “Standards for Human Stem Cell Use in Research” and growth factors for cell therapy manufacture

2024-07-25T16:45:56+00:00July 24th, 2024|animal-free, Blog, News, protein science, quality, Resources, stem cells|

Reflections on the dynamic ISSCR 2024 workshop on Standards for Human Stem Cell Use in Research including recommendations for growth factor supply chains for raw (ancillary materials) for cell therapy and ATMP manufacture.

24 07, 2024

The Cautionary Tale of GDF-15

2024-07-25T06:11:35+00:00July 24th, 2024|animal-free, Blog, News, protein science, quality, Resources|

Commercial sources of recombinant human GDF15 protein, in particular those purified from mammalian expression, are frequently contaminated with trace amounts of TGFβ and related proteins. These trace contaminants cause misleading experimental results due to the picomolar or even femtomolar EC50s of this family of cytokines.  Please be cautious with your source of recombinant GDF15 protein.

9 07, 2024

Qkine and StemCultures collaborate to provide new solutions for precision stem cell culture

2024-07-09T16:09:20+00:00July 9th, 2024|animal-free, Blog, News, Press Release, protein engineering, protein science, quality, Resources, stem cells|

Specialist bioactive growth factor protein manufacturer Qkine today announced a new partnership with StemCultures, a life sciences company dedicated to developing innovative reagents that enhance the quality and efficiency of cell growth and differentiation in culture.

20 06, 2024

Selection of growth factors and cytokines source for the manufacture of cell therapies, tissue-engineered products and translational stem cell research applications

2024-06-20T07:54:39+00:00June 20th, 2024|animal-free, Blog, News, Resources|

The manufacture of cell and gene therapy products and tissue-engineered regenerative medicine products often requires recombinant proteins such as growth factors and cytokines. These are classified as raw or ancillary materials ie. culture media components or reagents that are not intended to be included in the final product.

5 06, 2024

Transitioning to a fully animal origin-free recombinant protein manufacturing process

2024-06-10T12:23:43+00:00June 5th, 2024|animal-free, Blog, News, Resources|

We've recently fully transitioned to an animal origin-free (AOF) manufacturing process for our recombinant proteins. This shift ensures the highest standards of safety, purity, and sustainability in bioproduction. By eliminating all animal-derived components, including heparin-based purification columns, we’re supporting ethical and cruelty-free biomanufacturing. Learn more about our journey to 100% AOF.

Go to Top